Midway through a M.D./Ph.D program at UCLA, Alice Zhang made a discovery that she felt could reverberate far beyond the halls of academia. So she shifted directions, leaving her Ph.D program to found Verge Genomics, a biomedical firm that aims to unite genetic research and artificial intelligence in service of drug discovery. She describes how AI can revolutionize the drug discovery process, and reframes risk-taking as a simple series of optimistic next steps.
Related
Jessica Jackley,
Kiva
‘What If?’ Changes the World [Entire Talk]
Asking “What if?” can change the whole story.
Jessica Jackley,
Kiva
‘What If?’ Changes the World [Entire Talk]
Asking “What if?” can change the whole story.
Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.
Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.
Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.
Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.
